Your browser doesn't support javascript.
loading
The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy.
Guven, Deniz C; Kavgaci, Gozde; Aktepe, Oktay H; Yildirim, Hasan C; Sahin, Taha K; Aksoy, Sercan; Erman, Mustafa; Kilickap, Saadettin; Yalcin, Suayib.
Affiliation
  • Guven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
  • Kavgaci G; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Aktepe OH; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
  • Yildirim HC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
  • Sahin TK; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Aksoy S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
  • Erman M; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
  • Kilickap S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
  • Yalcin S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
J Oncol Pharm Pract ; 28(4): 785-793, 2022 Jun.
Article in En | MEDLINE | ID: mdl-33878976
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Polypharmacy / Neoplasms Limits: Aged / Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Polypharmacy / Neoplasms Limits: Aged / Humans Language: En Year: 2022 Type: Article